This formula contains GHK-Cu, SYN-AKE, Matrixyl synthe'6, Matrixyl 3000, ARGIRELOX peptide, Hyaluronic Acid, Amino Acids, and Bio-Derivatives
Any of these protocols should be clinician-directed, with baseline labs, a compliant compounding pharmacy, and a clear plan for how youll evaluate response at the 3-month mark
We typically start patients at a lower dose and gradually increase or adjust treatment based on results and tolerance from regular follow-up visits that monitor your progress
It is important to look at the context of this warning: Animal Studies: The warning is based on studies in rats and mice, where long-term exposure to these drugs led to the development of medullary thyroid carcinoma (MTC)
This approach would help in a more balanced way